Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a government funding status notice and a new version tag (v3.2.0); removed a specific resource (Hb SS disease) and the previous version tag (v3.1.0).SummaryDifference4% 
- Check33 days agoChange DetectedUpdate of chemical/material taxonomy and nomenclature, with a new revision tag (v3.1.0) replacing older terms from v3.0.2.SummaryDifference1% 
- Check47 days agoChange DetectedRevision: v3.0.2 added, replacing v3.0.1; the 'Back to Top' link was removed.SummaryDifference0.2% 
- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2% 
- Check62 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations, as well as detailed medical terms related to sickle cell anemia and various solutions. The revision number has also been updated to v3.0.0.SummaryDifference5% 
- Check76 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1% 
Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.